ID23794A - Proses, pembuatan dan penggunaan garam bentuk (2r, 3r) tartrat - Google Patents

Proses, pembuatan dan penggunaan garam bentuk (2r, 3r) tartrat

Info

Publication number
ID23794A
ID23794A IDW991407A ID991407A ID23794A ID 23794 A ID23794 A ID 23794A ID W991407 A IDW991407 A ID W991407A ID 991407 A ID991407 A ID 991407A ID 23794 A ID23794 A ID 23794A
Authority
ID
Indonesia
Prior art keywords
tartrat
manufacture
form salt
salt
Prior art date
Application number
IDW991407A
Other languages
English (en)
Inventor
Hakan Nyqvist
Daniel D Shohn
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ID23794A publication Critical patent/ID23794A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
IDW991407A 1997-05-30 1998-05-15 Proses, pembuatan dan penggunaan garam bentuk (2r, 3r) tartrat ID23794A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702066A SE510305C2 (sv) 1997-05-30 1997-05-30 Nytt salt

Publications (1)

Publication Number Publication Date
ID23794A true ID23794A (id) 2000-05-11

Family

ID=20407187

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991407A ID23794A (id) 1997-05-30 1998-05-15 Proses, pembuatan dan penggunaan garam bentuk (2r, 3r) tartrat

Country Status (33)

Country Link
US (2) US6858645B2 (id)
EP (1) EP0984952B1 (id)
JP (1) JP3554338B2 (id)
KR (1) KR20010013127A (id)
CN (1) CN1198814C (id)
AR (1) AR012751A1 (id)
AT (1) ATE228121T1 (id)
AU (1) AU729301B2 (id)
BG (1) BG64051B1 (id)
BR (1) BR9809519A (id)
CA (1) CA2291732C (id)
DE (1) DE69809547T2 (id)
DK (1) DK0984952T3 (id)
EE (1) EE03874B1 (id)
ES (1) ES2187030T3 (id)
HU (1) HUP0001878A3 (id)
ID (1) ID23794A (id)
IL (1) IL133234A (id)
IS (1) IS1943B (id)
MY (1) MY117960A (id)
NO (1) NO995853L (id)
NZ (1) NZ501075A (id)
PL (1) PL337181A1 (id)
PT (1) PT984952E (id)
RU (1) RU2193560C2 (id)
SE (1) SE510305C2 (id)
SK (1) SK282755B6 (id)
TR (1) TR199902926T2 (id)
TW (1) TW510899B (id)
UA (1) UA53720C2 (id)
WO (1) WO1998054166A1 (id)
YU (1) YU62499A (id)
ZA (1) ZA984486B (id)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
EP1534258A2 (en) * 2002-08-15 2005-06-01 Wyeth AGONISM OF THE 5HT 2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION
SE0301796D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use II
SE0301795D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use I
EP2022110B1 (en) * 2006-05-11 2011-10-12 Johnson Controls Saft Advanced Power Solutions LLC Modular battery system
JP5163931B2 (ja) * 2007-03-08 2013-03-13 株式会社リコー 定着装置及び画像形成装置
EP2065385A1 (en) * 2007-11-28 2009-06-03 Laboratorios SALVAT, S.A. Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester
CN101747305B (zh) * 2008-11-28 2014-06-18 中国医学科学院药物研究所 硝克柳胺化合物晶v型、其制法和其药物组合物与用途
HRP20190245T1 (hr) * 2013-04-26 2019-04-05 Sanofi Tartratna sol [(s)-2-[metil-3-(2-okso-pirolidin-1-il)-benzensulfonilamino]-3-(4-metil piperazin-1 -il)-3-okso-propril]amida 5-kloro-tiofen-2-karboksilne kiseline

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62231B1 (en) * 1987-12-24 1995-01-11 Wyeth John & Brother Ltd Heterocyclic compounds
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
US5616610A (en) * 1989-12-22 1997-04-01 Astra Aktiebolag (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
RU2047614C1 (ru) * 1992-06-15 1995-11-10 Джон Вайс энд Бразер Лимитед Гетероциклические соединения, или их фармацевтически приемлемые аддитивные соли кислоты, или n-оксид гетероциклического соединения, или его аддитивная соль кислоты
IT1282705B1 (it) 1996-02-28 1998-03-31 Recordati Chem Pharm Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence

Also Published As

Publication number Publication date
SE510305C2 (sv) 1999-05-10
CA2291732A1 (en) 1998-12-03
CA2291732C (en) 2003-12-30
NO995853L (no) 2000-01-31
US20030109576A1 (en) 2003-06-12
SE9702066D0 (sv) 1997-05-30
DE69809547T2 (de) 2003-08-21
WO1998054166A1 (en) 1998-12-03
AR012751A1 (es) 2000-11-08
US6858645B2 (en) 2005-02-22
HUP0001878A2 (hu) 2001-05-28
PT984952E (pt) 2003-03-31
ATE228121T1 (de) 2002-12-15
EE9900549A (et) 2000-06-15
BR9809519A (pt) 2000-06-20
HUP0001878A3 (en) 2002-04-29
IS1943B (is) 2004-08-13
NO995853D0 (no) 1999-11-29
SE9702066L (sv) 1998-12-01
PL337181A1 (en) 2000-08-14
CN1198814C (zh) 2005-04-27
JP3554338B2 (ja) 2004-08-18
HK1025575A1 (en) 2000-11-17
SK159499A3 (en) 2000-10-09
CN1258290A (zh) 2000-06-28
ES2187030T3 (es) 2003-05-16
ZA984486B (en) 1998-11-30
TW510899B (en) 2002-11-21
BG64051B1 (bg) 2003-11-28
SK282755B6 (sk) 2002-12-03
MY117960A (en) 2004-08-30
IS5270A (is) 1999-11-24
JP2002501527A (ja) 2002-01-15
KR20010013127A (ko) 2001-02-26
EP0984952A1 (en) 2000-03-15
IL133234A0 (en) 2001-03-19
AU7792398A (en) 1998-12-30
TR199902926T2 (xx) 2000-03-21
EE03874B1 (et) 2002-10-15
YU62499A (sh) 2002-06-19
UA53720C2 (uk) 2003-02-17
IL133234A (en) 2004-05-12
US20050085532A1 (en) 2005-04-21
DK0984952T3 (da) 2003-02-24
EP0984952B1 (en) 2002-11-20
DE69809547D1 (de) 2003-01-02
AU729301B2 (en) 2001-02-01
RU2193560C2 (ru) 2002-11-27
NZ501075A (en) 2001-08-31
BG103949A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
ID24929A (id) Turunan 2-aril-8-oksodihidropurin, proses pembuatannya, komposisi farmasinya yang mengandungnya, dan senyawa antaranya
ID30299A (id) Turunan oksazolidinon, proses pembuatannya dan komposisi farmasi yang mengandungnya
ID28787A (id) 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
ID18046A (id) Senyawa siklik campuran, pembuatan dan penngunaannya.
ID29950A (id) Bahan-bahan karbon amorf gabungan, pembuatan dan penggunaannya
ID28728A (id) Komposisi dan proses pengkrepan
ID27859A (id) Tampon dan metoda pembuatannya
ID20547A (id) Hasil adisi magnesium diklorida-alkohol, proses untuk penyediaannya dan komponen katalis yang dihasilkannya
ID21045A (id) Asam amino termodifikasi, obat-obatan yang mengandung senyawa ini dan proses pembuatannya
ID30393A (id) Senyawa tienopirimidina, pembuatan dan penggunaannya
ID26399A (id) Turunan 1-(1-tersubstitusi-4-piperidinil) metil -4-piperidin, proses pembuatannya, komposisi farmasi yang mengandung senyawa tersebut, dan intermedietnya
ID21337A (id) Katalis terdorong, proses pembuatannya, dan penggunaannya dalam oksiklorinasi etilene
ID22641A (id) Proses pembuatan e-kaprolaktam
ID29053A (id) Metode untuk menghasilkan 3-alkanoilindola dan 3-alkilindola
ID25898A (id) Pembungkus sterilisasi, penerapannya, dan metoda sterilisasi
ID16274A (id) Antagonis bradikinin heterosiklik pengganti-fluoroalkil dan fluoroalkoksi, proses pembuatan dan pemakaiannya
ID23387A (id) Proses dan zat antara untuk pembuatan asam 4'-trifluorometil-bifenil-2-karboksilat (1,2,3,4-tetrahidro-isokinolin-6-il)-amida
ID26660A (id) Proses pembuatan butana-1,4-diol, gamma-butirolakton dan tetrahidrofuran
ID24173A (id) 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan
ID18817A (id) 3-amidokromanilsulfonil (tio) urea, proses untuk pembuatan, penggunaan, dan sediaan-sediaan farmasi yang mengandungnya
ID26713A (id) Proses pembuatan katalis dan penggunaannya dalam sintesa, 1,2-dikloroetana
DE69926485D1 (de) Behandlung von durchblasgasen
EE9900549A (et) Uus sool
ID23037A (id) Aktivator katalis ion zwitter
ID27539A (id) Proses pembuatan senyawa-senyawa pirazolo [4,3-d]pirimidin-7-ona-3-piridilsulfonil dan senyawa-senyawa antaranya